- Home
- AGIO vs EXOD Comparison
AGIO vs EXOD Comparison
Compare AGIO & EXOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- EXOD
- Stock Information
- Founded
- AGIO 2007
- EXOD 2015
- Country
- AGIO United States
- EXOD United States
- Employees
- AGIO N/A
- EXOD N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- EXOD
- Sector
- AGIO Health Care
- EXOD
- Exchange
- AGIO Nasdaq
- EXOD NYSE
- Market Cap
- AGIO 1.4B
- EXOD 1.4B
- IPO Year
- AGIO 2013
- EXOD N/A
- Fundamental
- Price
- AGIO $27.66
- EXOD $36.58
- Analyst Decision
- AGIO Buy
- EXOD Strong Buy
- Analyst Count
- AGIO 8
- EXOD 3
- Target Price
- AGIO $56.57
- EXOD $59.33
- AVG Volume (30 Days)
- AGIO 745.1K
- EXOD 73.7K
- Earning Date
- AGIO 05-01-2025
- EXOD 05-12-2025
- Dividend Yield
- AGIO N/A
- EXOD N/A
- EPS Growth
- AGIO N/A
- EXOD 758.60
- EPS
- AGIO 11.64
- EXOD 3.52
- Revenue
- AGIO $36,498,000.00
- EXOD $116,272,000.00
- Revenue This Year
- AGIO $41.13
- EXOD $10.10
- Revenue Next Year
- AGIO $234.96
- EXOD $26.62
- P/E Ratio
- AGIO $2.38
- EXOD $10.38
- Revenue Growth
- AGIO 36.07
- EXOD 106.94
- 52 Week Low
- AGIO $23.42
- EXOD $8.00
- 52 Week High
- AGIO $62.58
- EXOD $117.40
- Technical
- Relative Strength Index (RSI)
- AGIO 44.94
- EXOD N/A
- Support Level
- AGIO $26.87
- EXOD N/A
- Resistance Level
- AGIO $28.24
- EXOD N/A
- Average True Range (ATR)
- AGIO 1.94
- EXOD 0.00
- MACD
- AGIO 0.22
- EXOD 0.00
- Stochastic Oscillator
- AGIO 66.15
- EXOD 0.00
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
About EXOD EXODUS MOVEMENT INC
Exodus Movement Inc is a self-custodial platform that connects people with the world of decentralized finance and the power of the blockchain. Available for desktop and mobile, it allows users to secure, manage and exchange cryptocurrencies like Bitcoin, Ethereum. Geographical presence in Europe, United States, the Middle East, and Africa (EMEA); Asia-Pacific (APAC); and Canada and Latin America (Other Americas).